Medpace director exercises 33 restricted stock units

Medpace Holdings, Inc. director Robert O. Kraft exercised 33 restricted stock units into 33 shares of common stock on March 31, 2026.

Accepted by SEC EDGAR 04/02/2026 - 04:42 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medpace Holdings, Inc. director Robert O. Kraft exercised 33 restricted stock units into 33 shares of common stock on March 31, 2026. This reflects the first vesting installment from a November 28, 2025 grant of 130 restricted stock units scheduled to vest quarterly through December 31, 2026. Following the transaction, he holds 922 shares of common stock directly and 97 restricted stock units representing an equal number of potential future shares.

Insider Trade Summary

33 shares exercised/converted

Exercise 2 txns

Insider Kraft Robert O.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	33	$0.00	$0.00
Exercise	Common Stock	33	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 97 contracts (Direct); Common Stock — 922 shares (Direct)

Holdings Before and After: Restricted Stock Unit, 130 to 97 contracts (Direct); Common Stock, 889 to 922 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
2. F2. On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Key Figures

RSUs exercised: 33 units Common shares held after: 922 shares RSUs remaining: 97 units +1 more

4 metrics

RSUs exercised 33 units Exercised into 33 common shares on March 31, 2026

Common shares held after 922 shares Direct ownership following March 31, 2026 transaction

RSUs remaining 97 units Restricted stock units outstanding after the exercise

Original RSU grant 130 units Granted November 28, 2025, vesting in four installments

Key Terms

Restricted Stock Unit, derivative security, contingent right

3 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

contingent right financial

"represents a contingent right to receive one share of MEDP common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MEDP director Robert O. Kraft report?

Robert O. Kraft reported exercising 33 restricted stock units into 33 shares of Medpace common stock. The transaction occurred on March 31, 2026 and was coded as an option or derivative security exercise rather than an open-market purchase or sale.

How many Medpace (MEDP) shares does Robert O. Kraft hold after this filing?

After the March 31, 2026 transaction, Robert O. Kraft directly holds 922 shares of Medpace common stock. He also holds 97 remaining restricted stock units, each representing a contingent right to receive one additional share of Medpace common stock in the future.

What are the terms of Robert O. Kraft’s MEDP restricted stock unit grant?

On November 28, 2025, Robert O. Kraft was granted 130 restricted stock units. These units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to the original grant’s conditions.

Did Robert O. Kraft buy or sell Medpace (MEDP) shares in the open market?

The filing shows no open-market buys or sells of Medpace shares. Instead, Robert O. Kraft exercised 33 restricted stock units at an effective price of $0.00 per share, converting derivative awards into common stock as part of his equity compensation.

How many Medpace (MEDP) restricted stock units does Kraft still have outstanding?

Following the March 31, 2026 vesting and exercise of 33 restricted stock units, Robert O. Kraft has 97 restricted stock units outstanding. Each remaining unit represents a contingent right to receive one Medpace common share as future installments vest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kraft Robert O.

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OHIO 45227

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		M		33	A	(1)	922	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/31/2026		M			33	(2)	(2)	Common Stock	33	$0	97	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

2. On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)